Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-valent pneumococcal conjugate vaccine co-administered with routine infant vaccines in healthy infants
2006-000558-30Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pneumococcal disease, meningococcal disease and Haemophilus influenzae type b disease (Hib) comparing 10-valent pneumococcal conjugate vaccine arm with Prevenar control arm (2 arms). Primary endpoint: Safety. Started Mar 2006; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinepneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal diseasemeningococcal diseaseHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2006-000558-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000558-30.